Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Vertex Pharmaceuticals (NQ:VRTX)

469.18 -8.14 (-1.71%)
Streaming Delayed Price Updated: 11:18 AM EST, Feb 18, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Vertex Pharmaceuticals

< Previous 1 2
...
24 25 26 27 28 29 30 31 32
...
71 72 Next >
News headline image
Vertex Pharmaceuticals (VRTX) Should Remain Supported ↗
Vertex Pharmaceuticals Incorporated (VRTX​​​​​​​), is a biotechnology company. It engages in developing & commercializing therapies for treating cystic fibrosis (CF). 
Via Talk Markets
News headline image
3 Reasons to Buy Vertex Pharmaceuticals Stock Like There's No Tomorrow ↗
Vertex shares have climbed almost 50% over the past year. 
Via The Motley Fool
News headline image
Median Drug Prices For Rare Diseases Hit $300K In 2023, Report Highlights Lack of Clear Rationale Behind Escalating Drug Prices ↗
Latest pharmaceutical trends in the U.S. as drug prices surged 35% in 2023. Uncover insights into the industry's focus on rare diseases, escalating costs, and the impact on FDA-approved drugs. 
Via Benzinga
News headline image
Is CRISPR Therapeutics the NVIDIA of gene editing?
CRISPR Therapeutics AG (NASDAQ: CRSP) made worldwide headlines when it and partner Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) received the first-ever FDA approv 
Via MarketBeat
Topics Artificial Intelligence
News headline image
What Analysts Are Saying About Vertex Pharmaceuticals Stock ↗
 
Via Benzinga
News headline image
Stock-Split Watch: Is Vertex Pharmaceuticals Next? ↗
It's on track to launch more blockbuster drugs. 
Via The Motley Fool
News headline image
The Ultimate Growth Stock to Buy With $1,000 Right Now ↗
The positives are many and the negatives are few with this high-flying stock. 
Via The Motley Fool
News headline image
2 Stocks That Could Crush the Market in 2024 ↗
These companies aren't slowing down, and their addressable markets are widening. 
Via The Motley Fool
News headline image
Three S&P 500 Giants Lead This List Of Stocks Near Buy Points ↗
Watch these five stocks, but the market is slightly extended. 
Via Investor's Business Daily
Topics Stocks
News headline image
Weight-Loss Drugs Have One Big Problem. These Drugmakers Are Taking It On. ↗
Weight-loss drugs from Novo Nordisk and Eli Lilly lead to massive weight loss. But not all of that weight loss is healthy. 
Via Investor's Business Daily
News headline image
The Best Stocks to Invest $5,000 in Right Now ↗
These stocks could be huge winners for long-term investors. 
Via The Motley Fool
News headline image
3 Biotech Stocks to Turn $10,000 Into $1 Million: February 2024 ↗
With new innovation and high demand, biotech stocks could offer some of the most explosive opportunities of the year. 
Via InvestorPlace
News headline image
3 Secret Stocks to Double Your Money by 2028 ↗
Vertex Pharmaceuticals (VRTX), UiPath (PATH), and Science Applications International (SAIC) are 3 secret stocks to double your money by 2028. 
Via InvestorPlace
News headline image
Vertex to Participate in Upcoming Investor Conferences
From Vertex Pharmaceuticals Incorporated
Via Business Wire
News headline image
Vertex Pharmaceuticals Is About to Extend Its Leadership in This Billion-Dollar Market ↗
Vertex's main business may be heading for a new era of growth... 
Via The Motley Fool
News headline image
Cathie Wood Is Betting on This Top Technology: 2 Stocks She Just Bought ↗
These exciting players could deliver explosive growth over time. 
Via The Motley Fool
News headline image
3 Revolutionary Biotech Stocks Poised for 10X Surge ↗
Discover three biotech stocks set to soar in a $3.08 trillion market, merging medical innovations with financial growth opportunities. 
Via InvestorPlace
News headline image
3 Magnificent Growth Stocks to Buy Right Now ↗
These stocks share at least two common denominators: a biopharmaceutical focus and great long-term prospects. 
Via The Motley Fool
News headline image
Could This News Upset Vertex Pharmaceuticals' Prospects in the Billion-Dollar Pain Management Market? ↗
The pain market is in great need of new options. 
Via The Motley Fool
News headline image
2 Top Growth Stocks to Buy With $1,000 Right Now ↗
Even a modest starting investment in the right stocks could pay off in the years ahead. 
Via The Motley Fool
News headline image
Vertex Pharmaceuticals Will Use $100 Million to Tank Its Own Market Share. Here's Why That's a Smart Move. ↗
Sometimes, the winning move doesn't look right at first. 
Via The Motley Fool
News headline image
2 Healthcare Growth Stocks That Are No-Brainer Buys Right Now ↗
The healthcare industry often remains resilient amid macro headwinds, and these two stocks are prime examples. 
Via The Motley Fool
News headline image
Giving Uber Its Due ↗
We've also got a look at good news from Chipotle and Roblox, and we put some stocks on a dating show. 
Via The Motley Fool
News headline image
Want $1 Million in Retirement? Invest $250,000 in These 3 Stocks and Wait a Decade. ↗
These stocks have what it takes to drive superior returns in the years to come. 
Via The Motley Fool
News headline image
Gene therapy: Why does it cost millions for a single treatment?
Gene therapy treatments have been making major headlines as advances in gene editing have gone mainstream thanks to the advent of CRISPR/Cas-9 technology. 
Via MarketBeat
News headline image
Is Vertex Pharmaceuticals Stock Too Expensive With a Price-to-Sales Ratio of 11x? ↗
There's more to consider with Vertex's valuation than one number. 
Via The Motley Fool
News headline image
If You Invested $10,000 in Vertex Pharmaceuticals in 2014, This Is How Much You Would Have Today ↗
You can't go back in the past, but it's not too late to invest in this top stock. 
Via The Motley Fool
News headline image
European Commission Approves First CRISPR/Cas9 Gene-Edited Therapy, CASGEVY™ (exagamglogene autotemcel), for the Treatment of Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia
From Vertex Pharmaceuticals Incorporated
Via Business Wire
News headline image
2 Healthcare Stocks That Could Help Set You Up for Life ↗
These rock-solid businesses can add meaningful returns to a long-term portfolio. 
Via The Motley Fool
News headline image
3 Groundbreaking Healthcare Stocks to Buy for Robust Gains ↗
Get the latest investment advice for healthcare stocks in 2024. Discover top picks and growth opportunities for the healthcare sector. 
Via InvestorPlace
< Previous 1 2
...
24 25 26 27 28 29 30 31 32
...
71 72 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.